James L. Januzzi

Research interests

Publications

• Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2401424

• Empagliflozin after Acute Myocardial Infarction

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2314051

• Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress Using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC

  European Journal of Heart Failure · 2023 · https://doi.org/10.1002/ejhf.3036

• Empagliflozin in Heart Failure with a Preserved Ejection Fraction

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2107038

• 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

  Journal of the American College of Cardiology · 2021 · https://doi.org/10.1016/j.jacc.2020.11.022

• Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

  European Journal of Heart Failure · 2021 · https://doi.org/10.1002/ejhf.2115

• Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association ( HFA ), European Society of Cardiology ( ESC )

  European Journal of Heart Failure · 2021 · https://doi.org/10.1002/ejhf.2346

• Inflammation in Heart Failure

  Journal of the American College of Cardiology · 2020 · 10.1016/j.jacc.2020.01.014

• Heart Failure With Reduced Ejection Fraction

  JAMA · 2020 · 10.1001/jama.2020.10262

• Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2022190

• Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection

  Journal of the American College of Cardiology · 2020 · https://doi.org/10.1016/j.jacc.2020.06.007

• Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations

  European Journal of Heart Failure · 2019 · 10.1002/ejhf.1494

• 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

  Journal of the American College of Cardiology · 2018 · https://doi.org/10.1016/j.jacc.2018.09.020

• Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1708454

• Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance

  Intensive Care Medicine · 2015 · https://doi.org/10.1007/s00134-015-4041-5

• 2013 ACCF/AHA Guideline for the Management of Heart Failure

  Journal of the American College of Cardiology · 2013 · 10.1016/j.jacc.2013.05.019

• 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

  Circulation · 2013 · 10.1161/cir.0b013e31829e8807

• Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

  International Journal of Cardiology · 2013 · https://doi.org/10.1016/j.ijcard.2013.01.228

• Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World

  Journal of the American College of Cardiology · 2013 · https://doi.org/10.1016/j.jacc.2013.09.072

• 2013 ACCF/AHA Guideline for the Management of Heart Failure

  Circulation · 2013 · 10.1161/cir.0b013e31829e8776

• Third Universal Definition of Myocardial Infarction

  Journal of the American College of Cardiology · 2012 · 10.1016/j.jacc.2012.08.001

• Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

  Circulation Cardiovascular Imaging · 2012 · 10.1161/circimaging.112.973321

• Third universal definition of myocardial infarction

  European Heart Journal · 2012 · 10.1093/eurheartj/ehs184

• Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

  Circulation · 2009 · 10.1161/circulationaha.108.844506

• Anemia and Mortality in Heart Failure Patients

  Journal of the American College of Cardiology · 2008 · 10.1016/j.jacc.2008.04.061

• Partial Thrombosis of the False Lumen in Patients with Acute Type B Aortic Dissection

  New England Journal of Medicine · 2007 · 10.1056/nejmoa063232

• Long-Term Survival in Patients Presenting With Type B Acute Aortic Dissection

  Circulation · 2006 · 10.1161/circulationaha.106.622340

• NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients

  European Heart Journal · 2005 · 10.1093/eurheartj/ehi631

• The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study

  The American Journal of Cardiology · 2005 · 10.1016/j.amjcard.2004.12.032

Current projects

No projects listed.